FDA Inspection 1258327 — Dagmara Makowska Mainka
The FDA completed an inspection of Dagmara Makowska Mainka on Dec 12, 2024 in Katowice. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 12, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Katowice (Poland)
Additional Details
Clinical Investigator (CI)